ALPA

Alpha Healthcare Acquisi... (ALPA)

Alpha Healthcare Acquisition Corporation III

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALPA

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/07/15	04 : 12	Business Wire	Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/27	21 : 29	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/27	21 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/27	20 : 00	Business Wire	Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/26	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/21	19 : 06	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/06/09	05 : 23	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/05/27	06 : 31	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/05/17	05 : 04	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/05/16	05 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/05/06	06 : 01	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/04/01	05 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/03/24	06 : 13	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/03/24	03 : 46	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/03/22	04 : 34	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/03/18	05 : 04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/15	02 : 50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/15	02 : 20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/14	21 : 34	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/14	20 : 21	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/07	06 : 30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/02/04	02 : 37	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/01/05	12 : 11	Business Wire	Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/01/05	07 : 19	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2023/01/05	07 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2022/11/11	06 : 25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2022/09/13	19 : 01	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2022/09/10	05 : 54	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2022/09/10	05 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III
2022/08/11	05 : 10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALPA	Alpha Healthcare Acquisition Corporation III